Ticker: CPIX

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) reported a 16% net revenue increase in Q2 2024, reaching $9.9 million. The company sees a bright future with strategic initiatives, expanding market presence, and positive clinical results, though it faces $52.5 million in liabilities.